ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
저분자 API 시장 규모는 최근 현저한 성장을 이루고 있습니다. 2025년 2,162억 7,000만 달러에서 2026년에는 2,325억 1,000만 달러에 이르고, CAGR 7.5%로 성장할 전망입니다. 지난 몇 년간의 성장은 의약품 개발 활동 증가, 제네릭 의약품 제조의 확대, 화학 합성 기술의 보급, 위탁 개발 서비스의 성장, 전 세계 의약품 소비량 증가에 기인하는 것으로 보입니다.
저분자 API 시장 규모는 향후 몇 년간 강력한 성장이 전망됩니다. 2030년에는 3,128억 3,000만 달러에 이르고, CAGR은 7.7%를 나타낼 전망입니다. 예측 기간 동안 성장 요인으로는 생산 능력 확대에 대한 투자 증가, 그린 케미스트리 기법 도입 확대, 종양학 및 중추신경계(CNS) 치료제 수요 증가, 개인맞춤형 의약품 파이프라인 확대, API 제조 자동화 발전 등을 꼽을 수 있습니다. 예측 기간의 주요 동향으로는 위탁생산(Outsourced API Manufacturing) 도입 확대, 공정 최적화 및 수율 개선의 중요성 증대, 고순도 저분자 API 수요 증가, 연속 생산 기술 보급, 규제 준수에 대한 관심 강화 등을 들 수 있습니다.
만성질환의 발생률 증가는 향후 저분자 API 시장의 확대를 촉진할 것으로 예측됩니다. 만성질환이란 3개월 이상 지속되고 시간이 지남에 따라 악화될 가능성이 있는 병태를 말합니다. 심혈관 질환, 당뇨병, 암 등의 질환은 지속적인 투약이 필요하며, 의약품 요법에 대한 안정적인 수요를 창출합니다. 저분자 API는 생체이용률 향상, 우수한 약동학, 부작용 감소를 실현하는 약물 개발을 촉진하고, 이러한 장기 질환의 치료 효과와 환자의 내약성을 향상시킬 수 있습니다. 예를 들어, 2023년 9월 스위스에 본부를 둔 유엔 전문기구인 세계보건기구(WHO)는 비감염성 질환(NCD) 또는 만성질환으로 인한 전 세계 연간 사망자 수가 4,100만 명에 달하고, 전체 사망자의 74%를 차지할 것이라고 보고했습니다. 이처럼 만성질환에 대한 부담이 증가하면서 저분자 API 시장의 성장을 견인하고 있습니다.
저분자 원료의약품 시장의 주요 기업들은 의약품 개발 촉진, 제조 공정의 효율화, 효과적인 의약품의 신속한 공급을 실현하기 위해 전략적 제휴를 우선적으로 추진하고 있습니다. 이번 제휴를 통해 치료제 개발 전문성과 탄탄한 제조 역량을 바탕으로 원활한 기술이전 및 저분자 원료의약품의 세계 공급이 가능해질 것으로 기대됩니다. 예를 들어, 2023년 3월 영국에 본사를 둔 제약회사 캣사이(CatSci Ltd.)는 스페인 AGC 파마케미컬(AGC Pharma Chemicals)과 파트너십을 맺고 의약품 개발을 강화했습니다. 캣사이의 비임상시험에 대한 전문 지식은 AGC의 강력한 제조 능력과 결합하여 임상 단계의 프로젝트를 지원하고 있습니다. AGC의 고객사들은 CatSci의 치료 개발의 최첨단 기술을 활용할 수 있으며, 저분자 API의 확장 가능한 생산과 다양한 기술을 중요시합니다. 이번 제휴는 효율적인 기술 이전을 통한 전략적 우위 창출, 의약품 개발 기간 단축, 그리고 영향력 있는 저분자 API 기반 의약품을 세계 시장에 공급하는 데 초점을 맞추었습니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 공급망 분석
제4장 세계 시장 동향과 전략
제5장 최종 이용 산업 시장 분석
제6장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세의 영향, 관세 전쟁과 무역 보호주의의 공급망에 대한 영향, 코로나 팬데믹이 시장에 미치는 영향을 포함한 거시경제 시나리오
제7장 세계 전략 분석 프레임워크, 현재 시장 규모, 시장 비교 및 성장률 분석
제8장 TAM(Total Addressable Market) 규모
제9장 시장 세분화
제10장 지역별/국가별 분석
제11장 아시아태평양 시장
제12장 중국 시장
제13장 인도 시장
제14장 일본 시장
제15장 호주 시장
제16장 인도네시아 시장
제17장 한국 시장
제18장 대만 시장
제19장 동남아시아 시장
제20장 서유럽 시장
제21장 영국 시장
제22장 독일 시장
제23장 프랑스 시장
제24장 이탈리아 시장
제25장 스페인 시장
제26장 동유럽 시장
제27장 러시아 시장
제28장 북미 시장
제29장 미국 시장
제30장 캐나다 시장
제31장 남미 시장
제32장 브라질 시장
제33장 중동 시장
제34장 아프리카 시장
제35장 시장 규제 상황과 투자환경
제36장 경쟁 구도와 기업 개요
제37장 기타 주요 기업 및 혁신 기업
제38장 세계 시장 경쟁 벤치마킹과 대시보드
제39장 주요 인수합병(M&A)
제40장 시장 잠재력이 높은 국가, 부문, 전략
제41장 부록
LSH
영문 목차
영문목차
Small molecule APIs (active pharmaceutical ingredients) are organic compounds with low molecular weights under 1 nm, typically consisting of 20-100 atoms, serving as active components in numerous biological and pharmaceutical processes, functioning as research tools to explore biological mechanisms, aid in creating novel therapeutic agents, and finding applications in pharmaceuticals and biological procedures.
The primary categories of small molecule APIs are synthetic and biotech. Synthetic describes a molecule created in a lab through diverse chemical methods. Small molecule API production options encompass in-house and outsourced approaches, serving uses in cardiology, oncology, CNS and neurology, orthopedics, endocrinology, and additional fields.
Tariffs are impacting the small molecule API market by increasing costs of imported chemical intermediates, solvents, catalysts, reactors, and analytical instruments used in API synthesis. Pharmaceutical manufacturers in North America and Europe are most affected due to reliance on imported raw materials from Asia, while Asia-Pacific faces cost pressures on API exports. These tariffs are raising production costs and affecting supply chain predictability. However, they are also driving regional API manufacturing investments, diversification of sourcing strategies, and increased focus on domestic API self-sufficiency.
The small molecule api market research report is one of a series of new reports from The Business Research Company that provides small molecule api market statistics, including small molecule api industry global market size, regional shares, competitors with a small molecule api market share, detailed small molecule api market segments, market trends and opportunities, and any further data you may need to thrive in the small molecule api industry. This small molecule api market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The small molecule api market size has grown strongly in recent years. It will grow from $216.27 billion in 2025 to $232.51 billion in 2026 at a compound annual growth rate (CAGR) of 7.5%. The growth in the historic period can be attributed to increasing pharmaceutical drug development activities, expansion of generic drug manufacturing, availability of chemical synthesis expertise, growth of contract development services, rising global medicine consumption.
The small molecule api market size is expected to see strong growth in the next few years. It will grow to $312.83 billion in 2030 at a compound annual growth rate (CAGR) of 7.7%. The growth in the forecast period can be attributed to increasing investments in capacity expansion, rising adoption of green chemistry practices, growing demand for oncology and CNS drugs, expansion of personalized medicine pipelines, increasing automation in api production. Major trends in the forecast period include increasing adoption of outsourced api manufacturing, rising focus on process optimization and yield improvement, growing demand for high-purity small molecule apis, expansion of continuous manufacturing techniques, enhanced emphasis on regulatory compliance.
The rising incidence of chronic diseases is projected to boost the small molecules API market in the future. Chronic diseases are illnesses that persist for three months or longer and may worsen over time. Conditions like cardiovascular diseases, diabetes, and cancer demand ongoing medication, creating steady demand for pharmaceutical therapies. Small-molecule APIs facilitate the development of drugs with enhanced bioavailability, better pharmacokinetics, and fewer side effects, which improves the efficacy and patient tolerance of treatments for these long-term conditions. For example, in September 2023, the World Health Organization-a Switzerland-based UN specialized agency-reported 41 million annual global deaths from non-communicable diseases (NCDs) or chronic diseases, accounting for 74% of all deaths. Thus, the growing burden of chronic diseases is fueling expansion in the small molecule API market.
Major companies in the small-molecule API market are prioritizing strategic partnerships to boost drug development, streamline manufacturing, and speed up the delivery of effective medicines. These alliances combine specialized knowledge in therapeutic development with robust manufacturing capacities, facilitating smooth technology transfer and worldwide availability of small-molecule APIs. For example, in March 2023, CatSci Ltd., a UK-based pharmaceutical firm, joined forces with AGC Pharma Chemicals, a Spain-based company, to strengthen drug development efforts. CatSci's expertise in non-clinical work now benefits from AGC's strong manufacturing capabilities, aiding projects in clinical phases. AGC's clients can tap into CatSci's cutting-edge skills in therapeutic development, emphasizing scalable production of small-molecule APIs and varied technologies. The partnership stresses efficient tech transfer to deliver strategic advantages, shorten drug development timelines, and bring high-impact small-molecule API-based medicines to global markets.
In February 2024, Suven Pharmaceuticals Limited, an India-based contract development and manufacturing organization (CDMO) and active pharmaceutical ingredient (API) provider, merged with Cohance Lifesciences to broaden its international manufacturing presence. Via this merger, the unified entity seeks to increase its small-molecule API production capacity and strengthen its worldwide CDMO presence through three specialized divisions: Pharma CDMO, Specialty Chemical CDMO, and API+. Cohance Lifesciences is an India-based merchant API platform focused on producing small molecule APIs.
Major companies operating in the small molecule api market are Merck & Co. Inc., AbbVie Inc., Bristol-Myers Squibb Company, Boehringer Ingelheim International GmbH, Dr. Reddy's Laboratories Ltd., Aurobindo Pharma, Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., Viatris Inc., Cambrex Corporation, Lonza Group AG, Siegfried Holding AG, AstraZeneca, F. Hoffmann-La Roche AG, Nanjing King-friend Biochemical Pharmaceutical Co. Ltd, Albany Molecular Research Inc., BASF SE, Gilead Sciences Inc., GlaxoSmithKline PLC, Johnson Matthey PLC, Novartis AG
North America was the largest region in the small molecule API market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the small molecule api market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the small molecule api market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The small molecules API market consists of sales of contract and captive small molecules API. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Small Molecule API Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses small molecule api market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on end user analysis.
Benchmark performance against key competitors based on market share, innovation, and brand strength.
Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for small molecule api ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The small molecule api market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Scope
Markets Covered:1) By Type: Synthetic; Biotech
2) By Manufacturer: In-House; Outsourced
3) By Application: Cardiology; Oncology; CNS And Neurology; Orthopedic; Endocrinology; Other Applications
Subsegments:
1) By Synthetic: Chemical Synthesis; Process Development; Custom Synthesis
2) By Biotech: Recombinant Proteins; Monoclonal Antibodies; Peptides
Companies Mentioned: Merck & Co. Inc.; AbbVie Inc.; Bristol-Myers Squibb Company; Boehringer Ingelheim International GmbH; Dr. Reddy's Laboratories Ltd.; Aurobindo Pharma; Sun Pharmaceutical Industries Ltd.; Teva Pharmaceutical Industries Ltd.; Viatris Inc.; Cambrex Corporation; Lonza Group AG; Siegfried Holding AG; AstraZeneca; F. Hoffmann-La Roche AG; Nanjing King-friend Biochemical Pharmaceutical Co. Ltd; Albany Molecular Research Inc.; BASF SE; Gilead Sciences Inc.; GlaxoSmithKline PLC; Johnson Matthey PLC; Novartis AG
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report
+ Excel Dashboard
Added Benefits
Bi-Annual Data Update
Customisation
Expert Consultant Support
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.
4.2.1 Increasing Adoption Of Outsourced API Manufacturing
4.2.2 Rising Focus On Process Optimization And Yield Improvement
4.2.3 Growing Demand For High-Purity Small Molecule APIs
4.2.4 Expansion Of Continuous Manufacturing Techniques
4.2.5 Enhanced Emphasis On Regulatory Compliance
5. Small Molecule API Market Analysis Of End Use Industries
5.1 Pharmaceutical Companies
5.2 Generic Drug Manufacturers
5.3 Contract Development And Manufacturing Organizations
5.4 Biotechnology Companies
5.5 Research Laboratories
6. Small Molecule API Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market
7. Global Small Molecule API Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis
7.1. Global Small Molecule API PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
7.2. Global Small Molecule API Market Size, Comparisons And Growth Rate Analysis
7.3. Global Small Molecule API Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
7.4. Global Small Molecule API Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)
8. Global Small Molecule API Total Addressable Market (TAM) Analysis for the Market
8.1. Definition and Scope of Total Addressable Market (TAM)
8.2. Methodology and Assumptions
8.3. Global Total Addressable Market (TAM) Estimation
8.4. TAM vs. Current Market Size Analysis
8.5. Strategic Insights and Growth Opportunities from TAM Analysis
9. Small Molecule API Market Segmentation
9.1. Global Small Molecule API Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Synthetic, Biotech
9.2. Global Small Molecule API Market, Segmentation By Manufacturer, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
In-House, Outsourced
9.3. Global Small Molecule API Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Cardiology, Oncology, CNS And Neurology, Orthopedic, Endocrinology, Other Applications
9.4. Global Small Molecule API Market, Sub-Segmentation Of Synthetic, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Chemical Synthesis, Process Development, Custom Synthesis
9.5. Global Small Molecule API Market, Sub-Segmentation Of Biotech, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
10. Small Molecule API Market Regional And Country Analysis
10.1. Global Small Molecule API Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
10.2. Global Small Molecule API Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
11. Asia-Pacific Small Molecule API Market
11.1. Asia-Pacific Small Molecule API Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
11.2. Asia-Pacific Small Molecule API Market, Segmentation By Type, Segmentation By Manufacturer, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
12. China Small Molecule API Market
12.1. China Small Molecule API Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
12.2. China Small Molecule API Market, Segmentation By Type, Segmentation By Manufacturer, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
13. India Small Molecule API Market
13.1. India Small Molecule API Market, Segmentation By Type, Segmentation By Manufacturer, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
14. Japan Small Molecule API Market
14.1. Japan Small Molecule API Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
14.2. Japan Small Molecule API Market, Segmentation By Type, Segmentation By Manufacturer, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
15. Australia Small Molecule API Market
15.1. Australia Small Molecule API Market, Segmentation By Type, Segmentation By Manufacturer, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
16. Indonesia Small Molecule API Market
16.1. Indonesia Small Molecule API Market, Segmentation By Type, Segmentation By Manufacturer, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
17. South Korea Small Molecule API Market
17.1. South Korea Small Molecule API Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
17.2. South Korea Small Molecule API Market, Segmentation By Type, Segmentation By Manufacturer, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
18. Taiwan Small Molecule API Market
18.1. Taiwan Small Molecule API Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
18.2. Taiwan Small Molecule API Market, Segmentation By Type, Segmentation By Manufacturer, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
19. South East Asia Small Molecule API Market
19.1. South East Asia Small Molecule API Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
19.2. South East Asia Small Molecule API Market, Segmentation By Type, Segmentation By Manufacturer, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
20. Western Europe Small Molecule API Market
20.1. Western Europe Small Molecule API Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
20.2. Western Europe Small Molecule API Market, Segmentation By Type, Segmentation By Manufacturer, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
21. UK Small Molecule API Market
21.1. UK Small Molecule API Market, Segmentation By Type, Segmentation By Manufacturer, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
22. Germany Small Molecule API Market
22.1. Germany Small Molecule API Market, Segmentation By Type, Segmentation By Manufacturer, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
23. France Small Molecule API Market
23.1. France Small Molecule API Market, Segmentation By Type, Segmentation By Manufacturer, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
24. Italy Small Molecule API Market
24.1. Italy Small Molecule API Market, Segmentation By Type, Segmentation By Manufacturer, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
25. Spain Small Molecule API Market
25.1. Spain Small Molecule API Market, Segmentation By Type, Segmentation By Manufacturer, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
26. Eastern Europe Small Molecule API Market
26.1. Eastern Europe Small Molecule API Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
26.2. Eastern Europe Small Molecule API Market, Segmentation By Type, Segmentation By Manufacturer, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
27. Russia Small Molecule API Market
27.1. Russia Small Molecule API Market, Segmentation By Type, Segmentation By Manufacturer, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
28. North America Small Molecule API Market
28.1. North America Small Molecule API Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
28.2. North America Small Molecule API Market, Segmentation By Type, Segmentation By Manufacturer, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
29. USA Small Molecule API Market
29.1. USA Small Molecule API Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
29.2. USA Small Molecule API Market, Segmentation By Type, Segmentation By Manufacturer, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
30. Canada Small Molecule API Market
30.1. Canada Small Molecule API Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
30.2. Canada Small Molecule API Market, Segmentation By Type, Segmentation By Manufacturer, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
31. South America Small Molecule API Market
31.1. South America Small Molecule API Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
31.2. South America Small Molecule API Market, Segmentation By Type, Segmentation By Manufacturer, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
32. Brazil Small Molecule API Market
32.1. Brazil Small Molecule API Market, Segmentation By Type, Segmentation By Manufacturer, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
33. Middle East Small Molecule API Market
33.1. Middle East Small Molecule API Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
33.2. Middle East Small Molecule API Market, Segmentation By Type, Segmentation By Manufacturer, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
34. Africa Small Molecule API Market
34.1. Africa Small Molecule API Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
34.2. Africa Small Molecule API Market, Segmentation By Type, Segmentation By Manufacturer, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
35. Small Molecule API Market Regulatory and Investment Landscape
36. Small Molecule API Market Competitive Landscape And Company Profiles
36.1. Small Molecule API Market Competitive Landscape And Market Share 2024
36.1.1. Top 10 Companies (Ranked by revenue/share)
36.2. Small Molecule API Market - Company Scoring Matrix
36.2.1. Market Revenues
36.2.2. Product Innovation Score
36.2.3. Brand Recognition
36.3. Small Molecule API Market Company Profiles
36.3.1. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
36.3.2. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
36.3.3. Bristol-Myers Squibb Company Overview, Products and Services, Strategy and Financial Analysis
36.3.4. Boehringer Ingelheim International GmbH Overview, Products and Services, Strategy and Financial Analysis
36.3.5. Dr. Reddy's Laboratories Ltd. Overview, Products and Services, Strategy and Financial Analysis
37. Small Molecule API Market Other Major And Innovative Companies
Aurobindo Pharma, Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., Viatris Inc., Cambrex Corporation, Lonza Group AG, Siegfried Holding AG, AstraZeneca, F. Hoffmann-La Roche AG, Nanjing King-friend Biochemical Pharmaceutical Co. Ltd, Albany Molecular Research Inc., BASF SE, Gilead Sciences Inc., GlaxoSmithKline PLC, Johnson Matthey PLC
38. Global Small Molecule API Market Competitive Benchmarking And Dashboard
39. Key Mergers And Acquisitions In The Small Molecule API Market
40. Small Molecule API Market High Potential Countries, Segments and Strategies
40.1 Small Molecule API Market In 2030 - Countries Offering Most New Opportunities
40.2 Small Molecule API Market In 2030 - Segments Offering Most New Opportunities
40.3 Small Molecule API Market In 2030 - Growth Strategies
